Literature DB >> 7673176

Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents. Identification by comparative protein phenotyping and microsequencing.

W F Patton1, H Erdjument-Bromage, A R Marks, P Tempst, M B Taubman.   

Abstract

Vascular smooth muscle cells (VSMC) are the principal cellular component of the blood vessel wall. Atherosclerosis, hypertension, and angiogenesis are associated with abnormal VSMC growth. Angiotensin II is hypertrophic for cultured adult rat aortic VSMC, whereas platelet-derived growth factor and serum are hyperplastic. To identify changes in specific proteins associated with either hyperplastic or hypertrophic growth, high resolution two-dimensional gel electrophoresis was performed on extracts from quiescent rat aortic VSMC and from VSMC exposed for 24 h to growth factors (10% fetal calf serum, platelet-derived growth factor, or angiotensin II). 12 proteins were up-regulated and 5 down-regulated by treatment with growth factors. Eight of the up-regulated and one of the down-regulated proteins were identified by internal protein microsequencing from electroblotted two-dimensional gels or by co-electrophoresis of purified proteins in two-dimensional gels. Four of the proteins up-regulated by growth factors were identified as mediators of protein folding. These were heat shock proteins, HSP-60 and HSP-70, protein disulfide isomerase, and protein disulfide isomerase isozyme Q-2. Additional proteins were identified as elongation factor EF-1 beta, a component of the protein synthesis apparatus, and calreticulin, another putative molecular chaperone. Vimentin and actin were also up-regulated, whereas an isoform of myosin heavy chain was down-regulated. Hyperplastic and hypertrophic growth were accompanied by similar changes in protein expression, suggesting that both types of growth require up-regulation of the protein synthesis and folding machinery.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673176     DOI: 10.1074/jbc.270.36.21404

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Epitranscriptional orchestration of genetic reprogramming is an emergent property of stress-regulated cardiac microRNAs.

Authors:  Yuanxin Hu; Scot J Matkovich; Peter A Hecker; Yan Zhang; John R Edwards; Gerald W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

2.  Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation.

Authors:  A D Schecter; P L Giesen; O Taby; C L Rosenfield; M Rossikhina; B S Fyfe; D S Kohtz; J T Fallon; Y Nemerson; M B Taubman
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

3.  Expression and effects of cardiotrophin-1 (CT-1) in human airway smooth muscle cells.

Authors:  Danyi Zhou; Xueyan Zheng; Lu Wang; Gerald Stelmack; Andrew J Halayko; Delbert Dorscheid; Tony R Bai
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

4.  Gene expression profile of butyrate-inhibited vascular smooth muscle cell proliferation.

Authors:  Kasturi Ranganna; Zivar Yousefipour; Frank M Yatsu; Shirlette G Milton; Barbara E Hayes
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

5.  Proteomic analysis of altered protein expression in skeletal muscle of rats in a hypermetabolic state induced by burn sepsis.

Authors:  Xunbao Duan; François Berthiaume; David Yarmush; Martin L Yarmush
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

6.  Calreticulin induces dilated cardiomyopathy.

Authors:  Dukgyu Lee; Tatsujiro Oka; Beth Hunter; Alison Robinson; Sylvia Papp; Kimitoshi Nakamura; Wattamon Srisakuldee; Barbara E Nickel; Peter E Light; Jason R B Dyck; Gary D Lopaschuk; Elissavet Kardami; Michal Opas; Marek Michalak
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

7.  Genetic Deletion of HLJ1 Does Not Affect Blood Coagulation in Mice.

Authors:  Man-Chen Hsu; Wei-Jia Luo; Bei-Chia Guo; Chia-Hui Chen; Po-An Hu; Yi-Hsuan Tsai; Kang-Yi Su; Tzong-Shyuan Lee
Journal:  Int J Mol Sci       Date:  2022-02-13       Impact factor: 5.923

8.  Proteomic Biomarkers of Atherosclerosis.

Authors:  F Vivanco; L R Padial; V M Darde; F de la Cuesta; G Alvarez-Llamas; Natacha Diaz-Prieto; M G Barderas
Journal:  Biomark Insights       Date:  2008-03-12

Review 9.  ERO1-PDI Redox Signaling in Health and Disease.

Authors:  Vishwanath Jha; Tripti Kumari; Vijayprakash Manickam; Zahra Assar; Kirk L Olson; Jeong-Ki Min; Jaehyung Cho
Journal:  Antioxid Redox Signal       Date:  2021-07-13       Impact factor: 8.401

10.  Inhibition of the Unfolded Protein Response Mechanism Prevents Cardiac Fibrosis.

Authors:  Jody Groenendyk; Dukgyu Lee; Joanna Jung; Jason R B Dyck; Gary D Lopaschuk; Luis B Agellon; Marek Michalak
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.